Press release
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of C. difficile bacteria. Common symptoms of clostridium difficile infection include watery diarrhea, dehydration, fever, nausea, loss of appetite, and weight loss. Life threatening symptoms of the disease includes abdominal distension, severe abdominal pain, and profuse diarrhea. Clostridium difficile infection management includes diagnosis of the infection using various tests and medication therapies using antibiotics such as Vancomycin and Fidaxomicin.Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1499
Rising prevalence of clostridium difficile infection is expected to boost growth of the market over the forecast period
Incidence of clostridium difficile infection has been witnessing an increase in the recent past, due to clostridium difficile infection recurrence and antibiotic resistance. According to Centers for Disease Control and Prevention (CDC), 2015, around half a million people in the U.S. suffer from clostridium difficile infection in a year. Moreover, according to National Center for Biotechnology Information (NCBI), an estimated 37,900 patients were suffering from clostridium difficile infection in Canada in 2012. A review and meta-analysis of studies published in National Center for Biotechnology Information (NCBI), 2016, conducted in China between 2010 and 2016 showed significant incidence of clostridium difficile infection in China. Furthermore, according to Canadian Antimicrobial Resistance Surveillance System 2017 Report, clostridium difficile infection may be a consequence of commonly prescribed antibiotics for unrelated infections. According to Organization for Economic Co-operation and Development (OECD), 2015, antibiotic resistant bacteria are highly prevalent in G7 countries. This high presence of antibiotic resistant bacteria may lead to increasing incidence of the infection, which in turn is expected to aid in growth of the global clostridium difficile diagnostics and treatment market.
The global clostridium difficile diagnostics and treatment market was valued at US$ 1,272.2 million in 2016 and is expected to witness a robust CAGR of 8.2% over the forecast period (2017–2025).
Robust pipeline of various therapies is expected to boost growth of the clostridium difficile treatment market over the forecast period
Standard antibiotic drugs such as metronidazole, Vancomycin, and Fidaxomicin have been used for the treatment of clostridium difficile infection (CDI) since the recent past. Currently, there is no alternative therapies apart from antibiotics available for the treatment of clostridium difficile infection and only option available is surgery (in severe cases), fecal microbiota transplant, and probiotics in case of recurrent clostridium difficile infection. However, Manufacturers such as Rebiotix, Inc., Synthetic Biologics, Inc., Da Volterra, Crestovo LLC, and Immuron Ltd. have various microbiome therapeutics (new class of drugs) in pipeline for clostridium difficile infection indication.
Rebiotix, Inc. has RBX7455 capsule in Phase 1 clinical trials, Synthetic Biologics Inc. has SYN-004 (ribaxamase) in Phase 2 clinical trials, and Da Volterra has DAV132 in clinical trials for antibiotic induced clostridium difficile infection. If these drugs show success in clinical trials, it could provide an alternative therapy for conventional antibiotics for treatment of the disease. Furthermore, probiotics are also gaining traction as they allow growth of natural flora through restoring natural balance of bacteria in the gut. Manufacturers such as Pfizer, Inc. and Valneva are working on developing novel vaccines for the treatment of CDI. For instance, Pfizer, Inc. has recombinant TcdA and TcdB PF-06425090 vaccine in phase 2 trial and Valneva has VLA84 in phase 1 trial.
Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/1499
However, low awareness about clostridium difficile infection symptoms and associated effects is expected to restrain the growth of the clostridium difficile diagnostics and treatment market over the forecast period.
Some major players operating in the clostridium difficile diagnostics and treatment market include Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Pfizer, Inc., Actelion Pharmaceuticals, Alere, Inc., Trinity Biotech, Summit Therapeutics, Baxter International Inc., Sanofi S.A., Novartis AG, and AstraZeneca Plc.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clostridium Difficile Diagnostics and Treatment Market – Insights here
News-ID: 1173907 • Views: …
More Releases from Coherent Market Insights
![Dental Compressor Market Is Booming Worldwide 2024-2031 | Air Techniques, DentalEZ Inc., Foshan Coredeep Medical Apparatus Co. Ltd](https://cdn.open-pr.com/L/9/L909574342_g.jpg)
Dental Compressor Market Is Booming Worldwide 2024-2031 | Air Techniques, Dental …
The latest market intelligence report published by CMI with the title "Global Dental Compressor Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Medical Devices industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Dental Compressor Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis.…
![Home Medical Equipment Market to See Booming Growth 2024-2031 | AstraZeneca, B. Braun Melsungen AG, Baxter, GE Healthcare](https://cdn.open-pr.com/L/9/L909341317_g.jpg)
Home Medical Equipment Market to See Booming Growth 2024-2031 | AstraZeneca, B. …
The latest market intelligence report published by CMI with the title "Global Home Medical Equipment Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Medical Devices industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Home Medical Equipment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR,…
![Tracheal Tube And Airway Products Market Overall Study Report 2024-2031 | Teleflex Inc., Smiths Medical, Medtronic Plc., Medis Medical (UK) Ltd](https://cdn.open-pr.com/L/9/L909436023_g.jpg)
Tracheal Tube And Airway Products Market Overall Study Report 2024-2031 | Telefl …
The latest market intelligence report published by CMI with the title "Global Tracheal Tube And Airway Products Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Medical Devices industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Tracheal Tube And Airway Products Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape,…
![Troponin Market Detailed In New Research Report 2024 | Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Response Biomedical](https://cdn.open-pr.com/L/9/L909204173_g.jpg)
Troponin Market Detailed In New Research Report 2024 | Roche Diagnostics, Abbott …
Troponin Market Trends Overview 2024-2031:
A new Report by Coherent Market Insights, titled "Troponin Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031," offers a comprehensive analysis of the industry, which comprises insights on the Troponin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Troponin…
More Releases for Clostridium
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of…
The Global Clostridium Difficile Infection Treatment Market Driver
Clostridium difficile, which produces gram-positive bacterium, is an anaerobic toxin that gets transmitted through fecal-oral route. Clostridium difficile infection occurs during antibiotic treatment or can be caused due to healthcare associated infection with clinical manifestation ranging from asymptomatic infection to watery diarrhea or serious intestinal condition such as colitis and colonic perforation. This infection can be diagnosed by enzyme immunoassays for toxins or Clostridium difficile glutamate dehydrogenase (GDH) and nucleic…
Clostridium difficile Infections (Clostridium difficile Associated Disease)Marke …
To Understand the pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Clostridium difficile Infections (Clostridium difficile Associated Disease)-Pipeline Review, H2 2017” to its vast database. This study offers data about the prime regions operating in the pharmaceutical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR…
Clostridium difficile Infections (Clostridium difficile Associated Disease)Marke …
To Understand the pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Clostridium difficile Infections (Clostridium difficile Associated Disease)-Pipeline Review, H2 2017” to its vast database. This study offers data about the prime regions operating in the pharmaceutical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR…
Clostridium Vaccine Market : Share, Analysis To 2024
The global clostridium vaccine (animal health) market features a largely consolidated competitive landscape, with the top five companies collectively accounting for a share of over 63% of the overall market in 2015, observes a recent report by Transparency Market Research (TMR). These top vendors, namely Zoetis, Inc., Merck & Co., Sanofi-Aventis, Boehringer Ingelheim, and Eli Lilly and Company hold commanding positions owing to their wide geographic presence and a strong…
Clostridium Vaccine Market to Grow Exponentially
Global Clostridium Vaccines Market: Snapshot
Clostridium vaccines are chiefly utilized for a variety of bovine and ovine clostridial diseases such as blackleg, pulpy kidney (enterotoxaemia), black disease, and tetanus. The demand for clostridium vaccine is rising globally owing to the increasing incidence rate of clostridium family diseases and increased awareness regarding zoonotic diseases. Rising concerns about the mortality of livestock animal and the socioeconomic impact of it on agrarian economies are…